Results 41 to 50 of about 3,471 (204)

Clinical efficacy and safety of use of alfacalcidol and calcitriol in daily endocrinological practice [PDF]

, 2023
This paper aims to discuss and compare 2 vitamin D derivatives available on the Polish market, alfacalcidol and calcitriol, in the context of their effectiveness and safety in endocrine patients.
Sewerynek, Ewa; Department of Endocrine Disorders and Bone Metabolism, Medical University of Lodz, Lodz, Poland, Michalska-Kasiczak, Marta; Department of Endocrine Disorders and Bone Metabolism, Medical University of Lodz, Lodz, Poland, Stuss, Michał; Department of Endocrine Disorders and Bone Metabolism, Medical University of Lodz, Lodz, Poland   +2 more
core   +1 more source

Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study

Frontiers in Medicine, 2022
BackgroundThe ability of extrarenal tissues to convert 25(OH)D (calcidiol) into 1,25(OH)2D (calcitriol) and dependence of the conversion on substrate levels provide the rationale for supplementing vitamin D in dialysis patients who usually have severe ...
Joanna Matuszkiewicz-Rowińska, Paweł Kulicki, Paweł Zebrowski, Wiesław Klatko, Antoni Sokalski, Stanisław Niemczyk, Magdalena Wypych-Birecka, Jolanta Małyszko   +7 more
doaj   +1 more source

Roles of active forms of vitamin D in supporting innate immune systems and in reducing excess inflammation in COVID-19

Терапевтический архив, 2021
A reduced supply of micronutrient vitamin D leads to a more severe course of coronavirus infection (COVID-19). Vitamin D deficiency is combined with a decrease in innate antiviral immunity and excess of inflammation.
Olga A. Gromova, Ivan I. Torshin, Alexander G. Chuchalin, Elena N. Kozhevnikova, Svetlana I. Malyavskaya   +4 more
doaj   +1 more source

Otsenka riska padeniy zhenshchin s postmenopauzal'nymosteoporozom, poluchayushchikh al'fakal'tsidol

Остеопороз и остеопатии, 2010
The study objective: to assess the influence of alfacalcidol treatment on risk of falling in real clinical practice. Methods. Prospective cohort study included 46 postmenopausal women aged from 52 to 78, who had high risk of falling, low bone mineral ...
M. V. Strunina, M. V. Telyushchenko, A. A. Popov, N. V. Izmozherova   +3 more
doaj   +1 more source

Daily calcium profile in diagnosis of hypo- and hypercalcemia in patients with chronic hypoparathyroidism. clinical case series

Ожирение и метаболизм, 2021
Hypoparathyroidism is a rare endocrine disorder characterized by hypocalcemia and hyperphosphatemia, due to absent or inappropriately low serum parathyroid hormone (PTH) levels.
E. V. Kovaleva, A. K. Eremkina, N. G. Mokrysheva   +2 more
doaj   +1 more source

Estimated association of dialysate calcium concentration with the two outcomes stratified by use of alfacalcidol.

, 2022
Estimated association of dialysate calcium concentration with the two outcomes stratified by use of alfacalcidol.
Masaaki Inaba (172320), Ayumi Shintani (11873), Shinya Nakatani (522972), Katsuhito Mori (522971), Daijiro Kabata (4966756), Tetsuo Shoji (172301), Kunitoshi Iseki (636721), Masanori Emoto (172308), Tomoaki Morioka (522973)   +8 more
core   +1 more source

The efficacy of combined treatment of secondary hyperthyroidism in pre-dialysis chronic kidney disease patients

Bolʹ, Sustavy, Pozvonočnik, 2023
Background. It is well known that chronic kidney di­sease (CKD) patients develop mineral and bone disturbances which lead to the development of renal osteodystrophy and its complications.
L.P. Martynyuk, O.I. Shershun, T.L. Malska   +2 more
doaj   +1 more source

Treatment of renal transplant recipients with low bone mineral density: A randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol

, 2008
We sought to compare the treatment modalities of alendronate, alfacalcidol, and alendronate combined with alfacalcidol in renal transplant recipients with low bone mineral density.
Trabulus, S., Serdengecti, K., Altiparmak, M. R., Sariyar, M., Apaydin, S.   +4 more
core   +1 more source

Association Between Secondary Hyperparathyroidism and Body Composition in Pediatric Patients With Moderate and Advanced Chronic Kidney Disease

Frontiers in Pediatrics, 2021
Objective: This single center cross-sectional study aims to investigate the association between secondary hyperparathyroidism and body composition in pediatric patients with moderate (stage 3) and advanced (stage 4–5) chronic kidney disease (CKD).Methods:
Vasiliki Karava, Antonia Kondou, John Dotis, Athanasios Christoforidis, Anna Taparkou, Konstantina Tsioni, Evangelia Farmaki, Konstantinos Kollios, Ekaterini Siomou, Vassilios Liakopoulos, Nikoleta Printza   +10 more
doaj   +1 more source

Vitamin D Supplementation to Prevent Post‐Thyroidectomy Hypocalcemia

Clinical Endocrinology, Volume 105, Issue 2, Page 259-266, August 2026.
ABSTRACT Objective Hypocalcemia is the most common complication following thyroidectomy. Previous studies yielded inconsistent results on whether vitamin D3 prevents postoperative hypocalcemia and were conducted in non‐European countries with different dietary habits and baseline vitamin D levels.
Jeresa I. A. Willems, Daan J. L. van Twist, Kristy M. Pickwell, Patrick L. H. van Battum, Rutgert Bianchi, Annette M. Pijnenburg, James van Bastelaar, Marco Medici, Robin P. Peeters, Roderick F.A. Tummers‐de Lind van Wijngaarden   +9 more
wiley   +1 more source